Aegerion Pharmaceuticals, Inc.·5

Feb 12, 4:01 PM ET

Aegerion Pharmaceuticals, Inc. 5

5 · Aegerion Pharmaceuticals, Inc. · Filed Feb 12, 2014

Insider Transaction Report

Form 5
Period: 2013-12-31
Fitzpatrick Mark J.
Chief Financial Officer
Transactions
  • Gift

    Common Stock

    2013-11-181005,750 total
  • Gift

    Common Stock

    2013-11-18+100100 total(indirect: By Daughter)
Footnotes (1)
  • [F1]This transaction involved a gift of securities by the reporting person to his daughter, who shares reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his daughter, and this report should not be deemed an admission that the reporting person is the beneficial owner of his daughter's shares for purposes of Section 16 or for any other purpose.

Documents

1 file
  • 5
    rrd402248.xmlPrimary

    FORM 5